Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PerkinElmer Inc (NYSE:PKI)

During the Trading Day
53.16 -0.42 / -0.78%
As of 4:03pm ET
Day’s Change
During After-Hours   Switch to standard view »
53.16 +0.002 / +0.00%
Volume: 48.5K
Health Technology
Medical Specialties

Company Description

PerkinElmer, Inc. (United States) engages in the provision of products and solutions to diagnostics, research, and laboratory services. it operates through the Human Health and Environmental Health segments. The Human Health segment researches and develops therapies such as genetic disorder detections, screening products, infectious disease testing, drug discoveries. The Environmental Health segment produces and sells products and solutions which include harmful substances detection in food, water, and surroundings. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.

Contact Information

PerkinElmer, Inc. (United States)
940 Winter Street
Waltham Massachusetts 02451
P:(781) 663-6900
Investor Relations:
(781) 663-5889



Mutual fund holders65.58%
Other institutional26.85%
Individual stakeholders2.12%

Top Executives

Robert F. FrielChairman, President & Chief Executive Officer
Frank Anders WilsonChief Financial Officer & Senior Vice President
Jonathan DiVincenzoPresident-Environmental Health & Senior VP
Andrew OkunCAO, Vice President & Principal Accounting Officer
John Leo HealyVice President